BLOG

Stuff that matters.

Alkem Labs to expand in domestic as well as international markets

16 Aug 2017

Drug firm Alkem Laboratories is looking to tap domestic as well as international markets for growth going forward, the company has said. In the domestic market, the company plans to consolidate presence in the segments it is in and is aiming to build base in the emerging therapy areas and OTC segment....

Read More

New rules to regulate marketing by drug makers to ensure a crackdown on unethical practices

07 Aug 2017

India, one of the world's largest markets for pharmaceuticals, is drawing up its first set of marketing rules for drugmakers, restricting gifts and trips offered to doctors and pharmacists to Rs 1,000 rupees, according to a draft proposal.  While such rules are common elsewhere in the world...

Read More

Cipla launches anti-malaria drug for young children

26 Jul 2017

Drug major Cipla in partnership with Medicines for Malaria Venture (MMV) today launched a drug used for the treatment of severe malaria in young children.  The company introduced 100 mg Artesunate Rectocaps/Rectal Artesunate Suppositories (RAS), a life-saving, pre-referral intervention for the...

Read More

Biocon hits the right notes with its Brest Cancer Drug at the USFDA, gets approval.

19 Jul 2017

India's largest biopharma company got an approval for its proposed biosimilar brest cncer drug Trastuzumab from the the US Food and Drug Administration. This opens doors for Bangalore based Biocon in the big league of US cancer drug market. The drug is developed in conjunction with US drug maker...

Read More

Indian pharma firms need to increase R&D investment to compete globally

18 Jul 2017

According to a report published by S&P Global Ratings, Indian pharma firms need to increase investments in research and development and quality of manufacturing to comply with global regulatory standards and take on competition. "We believe Indian pharma companies will feel growing pains,...

Read More

LifeCell's innovation gets global recognition

13 Jul 2017

LifeCell International (India's first and the largest stem cell bank)has made an entry into global platform with their recently launched concept of 'Community Stem Cell Banking'. It is believed to be a general practice that technological advancements and new concepts from the western world...

Read More

Glenmark gets US FDA nod for high blood pressure medicine

07 Jul 2017

The US arm of Indian pharmaceutical major Glenmark Pharmaceuticals has been granted final approval by the United States Food and Drug Administration (US FDA) for its generic version Olmesartan Medoxomil Tablets. These are generic equivalent of Benicar Tablets of  Japanese drug maker Daiichi...

Read More

Indian biotech start-ups attract $2.8 bn in investments in last 5 years

06 Jul 2017

India has over 3,000 entrepreneurs, one third of whom are women, who have started biotechnology firms in the past five years and have raised a combined total of $2.8 billion or Rs 18,700 crore in the same period. These entrepreneurs have formed 1,022 biotechnology start-ups in the period...

Read More

Bangalore based startup inks a $3 M deal with MMC Pharma

05 Jul 2017

Innov4Sight Health and Biomedical Systems Private Limited, a Bangalore based startup, has inked a strategic licensing deal with MMC Pharmaceuticals. This deal will generate more $ 3 Million over the next 18 months. As part of this deal MMC Pharma's offshoot InnoBioLabs LLP will be investing over...

Read More

Innovate in India: The Flagship program that promises to be a game changer in Biopharma Production

04 Jul 2017

The Ministry of science and technology has launched a flagship program that promises to be a game changer and promote production of biological drugs here in India.  This is a $250 million program that received an approval of the cabinet ministry in May, will focus on development of new vaccines,...

Read More

Government gets Rs 672 crore fine from pharma companies for overcharging.

15 Mar 2017

NEW DELHI: Drug pricing regulator NPPA has received Rs 672.28 crore fine till date from pharmaceutical companies for overcharging, Parliament was informed today.  Since inception, the National Pharmaceutical Pricing Authority (NPPA) has issued 1,527 demand notices to companies for overcharging...

Read More

Pharma makes most super rich in India

08 Mar 2017

Over 15 per cent of Indian billionaires are from pharma, followed by manufacturing.   Mumbai: The pharmaceutical sector has produced the most number of ultra high net-worth individuals in India, accounting for almost 16 per cent of the total 132 wealthy Indians featured in the latest...

Read More

Indian-American Entrepreneur Under Consideration To Lead USFDA.

06 Mar 2017

  Balaji Srinivasan met Trump at the Trump Towers in New York on Thursday. No official announcement has been made yet. Press Trust of India       Washington: Indian-American Balaji S Srinivasan, a successful Silicon Valley-based entrepreneur and CEO of a...

Read More

US Pharma Sector Demands Keeping India In Patent Violator List

06 Mar 2017

  Among the key issues of concern for the US pharma sector in India are unpredictable IP environment, high tariffs and taxes on medicines among others. Press Trust of India  Washington: America's pharma sector has asked US Trade Representative (USTR) to continue to keep India...

Read More

Cipla To Sell Animal Health Business In South Africa.

06 Mar 2017

Under the agreements, Cipla will divest its 100 per cent stake in Cipla Agrimed Proprietary South Africa and Cipla Vet Proprietary, South Africa, it said. New Delhi: Pharma firm Cipla today said it plans to sell its animal health business in South Africa and Sub-Saharan Africa for a consideration...

Read More

Abbott to make India hub of global research and development for branded generics.

07 Feb 2017

At a time when multinational drug companies are scaling down their research and development investments in India, citing lax patent rules and increasing regulatory interventions, the US based multinational Abbott is planning to make India its global hub for innovation and development (I&D), in branded...

Read More

Trump tells pharma CEOs to cut costs and bring back jobs

07 Feb 2017

President Donald Trump met with CEOs of some of America's biggest and most profitable pharmaceutical companies at the White House on Tuesday, saying he expects them to lower drug prices and bring jobs back to the United States. 'You folks have done a terrific job over the years, but we...

Read More

Get in touch

For any questions or suggestions, please feel free to get in touch with us

Get in touch

Social

Like us on facebook to get updates on latest jobs.